by Alyssa had undergone chemotherapy and a bone marrow transplant – but her leukaemia remained. She then received genetically-edited T-cells in the first use of the therapy at Great Ormond Street.Alyssa had undergone chemotherapy and a bone marrow transplant – but her leukaemia remained. She then received genetically-edited T-cells in the first use of the therapy at Great Ormond Street.Read MoreHealth News | Mail Online
